Sigmoid Pharma

16 results

Ireland’s largest estate agent Sherry FitzGerald paid a dividend of just more than over €1 million to shareholders last year

Ireland’s largest estate agent Sherry FitzGerald paid a dividend of just more than over ¤1 million to shareholders last year on the back of strong sal(...)

Alex Hobbs, chairman and Sarah-Jane Larkin, director general, Irish Venture Capital Association. The IVCA has urged the Government to act following weak investment figures. Photograph: Colm Mahady/Fennell Photography

Venture capital funding into Irish tech firms fell by 9 per cent in the first half of 2018, the first time that the funding has fallen since 2011. Th(...)

Dr Albert Agro, chief executive of Sublimity Therapeutics.

Irish-founded pharma company Sublimity Therapeutics, which closed a $64 million (€55 million) round in May, has said it will need to raise “significan(...)

 Sublimity’s chief technology officer Ivan Coulter

Irish-founded pharma company Sublimity Therapeutics is considering a potential flotation as it looks to get its flagship solution to market within the(...)

 Ivan Coulter, chief executive of Sigmoid Pharma.

Irish pharma company Sublimity Therapeutics (formerly Sigmoid Pharma), has closed a $64 million (€54.7 million) financing round to fund the developmen(...)

Invent DCU  was set up in 2001 to forge better links between researchers and industry

Dublin City University’s innovation campus is looking to significantly expand and is also in talks about a private-public partnership (PPP) to create (...)

 Ivan Coulter from Sigmoid Pharma: Its deal with Dr Falk Pharma is reported to be worth more thna €100m. Photograph: Alan Betson

With Brexit centre stage, there is a temptation for all attention in Ireland to focus on two topics: how much the move might damage our economy; and w(...)

Sigmoid chief executive Ivan Coulter highlights the ‘very powerful validation’ the involvement of Dr Falk Pharma brings Sigmoid.

Speciality drug group Sigmoid Pharma has signed a landmark partnership with one of the biggest players in gastrointestinal therapy. The deal with fami(...)

DCU Invent has 2,800 square metres of incubation space for technology start-up firms

Dublin City University’s innovation centre Invent, which was set-up in 2001 to forge better links between researchers and industry, saw losses narrow(...)

 Sigmoid Pharma founder Ivan Coulter said the Freund acquisition “will enable us to advance our lead programmes”. Photograph: Alan Betson

Speciality drug business Sigmoid Pharma has agreed to buy the Irish business of Japanese pharmaceutical equipment group Freund. The transaction, the(...)

  • 1
  • 2
  • Next
  • Last »